The research on the immunoregulatory effect of programmed death-1 (PD-1) in infectious diseases mainly focuses on chronic viral infection, but there are few studies on acute viral infection. In chronic viral infection, PD-1 is highly expressed on the surface of CD8 T cells, which is a sign of CD8 T cell depletion. Recent studies have shown that in chronic viral infection, PD-1 is also highly expressed on the surface of regulatory T cells and binds to programmed death-ligand 1 (PD-L1) on the surface of exhausted CD8 T cells, resulting in a stronger inhibitory effect on CD8 T cell immunity. Blocking the PD-1/PD-L1 signaling pathway between exhausted CD8 T cells and regulatory T cells can significantly reverse the depletion of CD8 T cells and greatly improve the antiviral effect of CD8 T cells. However, the role of the PD-1/PD-L1 signaling pathway in acute viral infection remains unknown. This article summarizes the latest research on PD-1 in infectious diseases and discusses its role in acute and chronic viral infection.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390312 | PMC |
http://dx.doi.org/10.7499/j.issn.1008-8830.2018.01.016 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!